IP Library Granted Patent US 10,201,301
Granted Patent B2
US 10,201,301 · App. 15/132,231 · Granted Feb 12, 2019

Analyte monitoring device and methods of use

Inventors: Adam Heller (Austin, TX); Benjamin Jay Feldman (Berkeley, CA); Shridhara Alva Karinka (Pleasanton, CA); Yi Wang (San Ramon, CA); John R. Galasso (Saint Helena, CA)
Assignee: Abbott Diabetes Care Inc.
A61B5/1495A61B5/0031A61B5/1451A61B5/1473A61B5/1477A61B5/14532A61B5/14542A61B5/14546A61B5/14865A61B5/4839A61B5/4848A61B5/7246A61B5/7275A61B5/7278A61B5/7282A61B5/742A61B5/7405A61B5/746A61B5/7445A61B5/7455A61B17/3468G01N27/3272G01N27/3273A61B2017/3407A61B2017/3409A61B2560/0209A61B2560/0475A61B2562/0271A61B2562/0295A61B2562/085A61B2562/125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,201,301
App. No.
15/132,231
Granted
Feb 12, 2019
Kind
B2
Abstract

In aspects of the present disclosure, a no coding blood glucose monitoring unit including a calibration unit is integrated with one or more components of an analyte monitoring system to provide compatibility with in vitro test strip that do not require a calibration code is provided. Also disclosed are methods, systems, devices and kits for providing the same.

Claims (35)

1. An apparatus, comprising:

an analyte sensor interface for communicatively coupling with an in vivo analyte sensor configured to be in contact with bodily fluid under a skin surface;

one or more processors; and

a memory, the memory storing instructions which, when executed by the one or more processors, causes the one or more processors to:

receive information for one or more measurements made by the in vivo analyte sensor, including at least a first parameter;

receive information for one or more measurements made by an in vitro analyte sensor, including at least a second parameter, the in vitro analyte sensor having a type;

recognize the type of the in vitro analyte sensor without a user input as a no-coding in vitro analyte sensor based on the received information;

validate the first parameter with the second parameter; and

determine using the one or more processors, an analyte level based on the received information for the one or more measurements made by the in vitro analyte sensor, the information for the one or more measurements made by the in vivo analyte sensor, and a universal calibration parameter that is associated with no-coding in vitro analyte sensors.

2. The apparatus of claim 1 , wherein the universal calibration parameter is a standard calibration code, and the in vitro analyte sensor is manufactured to fit the standard calibration code.

3. The apparatus of claim 1 , the memory storing instructions to process one or more time spaced signals generated by the in vivo analyte sensor.

4. The apparatus of claim 3 , wherein the bodily fluid includes dermal fluid.

5. The apparatus of claim 3 , wherein the bodily fluid includes interstitial fluid.

6. The apparatus of claim 3 , wherein the analyte level is related to one or more of a glucose level, lactate level, or oxygen level.

7. The apparatus of claim 3 , wherein the in vivo analyte sensor includes a plurality of electrodes including a working electrode comprising an analyte-responsive enzyme.

8. The apparatus of claim 7 , wherein the enzyme is bound to a polymer disposed on the working electrode.

9. The apparatus of claim 7 , wherein the working electrode comprises a mediator.

10. The apparatus of claim 9 , wherein the mediator is bound to a polymer disposed on the working electrode.

11. The apparatus of claim 9 , wherein the mediator is crosslinked with a polymer disposed on the working electrode.

12. The apparatus of claim 3 , wherein the in vivo analyte sensor includes a plurality of electrodes including a working electrode comprising a mediator.

13. The apparatus of claim 12 , wherein the mediator is bound to a polymer disposed on the working electrode.

14. The apparatus of claim 12 , wherein the mediator is crosslinked with a polymer disposed on the working electrode.

15. A system, comprising:

an in vivo analyte sensor configured to be in contact with bodily fluid under a skin surface; and

a device to operatively couple with the in vivo analyte sensor, the device including an analyte sensor interface for communicatively coupling with the in vivo analyte sensor, one or more processors, and a memory, the memory storing instructions which, when executed by the one or more processors, causes the one or more processors to:

receive information for one or more measurements made by the in vivo analyte sensor, including at least a first parameter;

receive, using the one or more processors, information for one or more measurements made by an in vitro analyte sensor, including at least a second parameter, the in vitro analyte sensor having a type;

recognize, using the one or more processors, the type of the in vitro analyte sensor without a user input as a no-coding in vitro analyte sensor based on the received information;

validate the first parameter with the second parameter; and

determine, using the one or more processors, an analyte level based on the received information for the one or more measurements made by the in vitro analyte sensor, the information for the one or more measurements made by the in vivo analyte sensor, and a universal calibration parameter that is associated with no-coding in vitro analyte sensors.

16. The system of claim 15 , wherein the universal calibration parameter is a standard calibration code, and the in vitro analyte sensor is manufactured to fit the standard calibration code.

17. The system of claim 16 , wherein the device is further configured to process, using the one or more processors, one or more time spaced signals generated by the in vivo analyte sensor.

18. The system of claim 17 , wherein the bodily fluid includes dermal fluid.

19. The system of claim 17 , wherein the bodily fluid includes interstitial fluid.

20. The system of claim 17 , wherein the analyte level is related to one or more of a glucose level, lactate level, or oxygen level.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2016
From: HELLER, ADAM; FELDMAN, BENJAMIN JAY; KARINKA, SHRIDHARA ALVA; WANG, YI; GALASSO, JOHN R.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 038448/0041 →
Continuity (5)
Continuation 14562625 · Dec 5, 2014
Continuation 14229520 · Mar 28, 2014
Continuation 12495798 · Jun 30, 2009
Continuation In Part 11265787 · Nov 1, 2005
Related Publication 20160228041A1 · Aug 11, 2016
Cited By (16)
US 12,290,359 US 12,385,077 US 12,398,413 US 12,575,769 US 12,577,603 US 12,577,604 US 12,588,844 US 12,594,013 US 12,594,014 US 12,672,803 US 12,672,804 US 12,672,805 US 12,686,881 US 12,686,882 US 12,693,255 US 12,698,517